1 In isolated tissue experiments, neurokinin A (NKA) produced concentration-dependent contraction of human and guinea-pig ureter (pD 2 =6.7 and 7.2, respectively); an eect greatly reduced (480% inhibition) by the tachykinin NK 2 receptor-selective antagonist MEN 11420 (0.1 mM). The tachykinin NK 1 and NK 3 receptor agonists septide and senktide, respectively, were ineective. 2 Electrical ®eld stimulation (EFS) of the guinea-pig isolated renal pelvis produced an inotropic response blocked by MEN 11420 (0.01 ± 1 mM). In the same preparation MEN 11420 (0.1 mM) blocked (apparent pK B =8.2) the potentiation of spontaneous motor activity produced by the NK 2 receptorselective agonist [bAla 8 ]NKA(4 ± 10).
Introduction
The mammalian tachykinins, substance P (SP), neurokinin A (NKA) and neurokinin B (NKB), are widely distributed in the central and peripheral nervous system. The most widespread and extensively investigated biological eect exerted by tachykinins in the peripheral nervous system is smooth muscle contraction, produced through the activation of speci®c membrane receptors termed NK 1 , NK 2 and NK 3 Guard & Watson, 1991; Maggi et al., 1993) . Recently, evidence has been provided for the existence of a structurally distinct subtype of the NK 3 receptor, also termed NK 4 (Donaldson et al., 1996; Krause et al., 1997) , but the relevance of this receptor in the peripheral eects of tachykinins is presently unsettled.
In the rat and guinea-pig renal pelvis and ureter, tachykinins (SP and NKA) are co-stored with calcitonin gene-related peptide (CGRP) in the peripheral endings of capsaicin-sensitive primary aerent neurons. SP and NKA are released from these sensory nerve endings to produce motor responses which are involved in the local regulation of pyeloureteral motility (see Maggi, 1995, for review) . In particular, both NKA and SP produce contraction of the rat and guinea-pig, isolated ureter, characterized by the appearance of rhythmic and long-lasting phasic contractions (Hua & Lundberg, 1986; Maggi et al., 1986 Maggi et al., , 1987 Nagahisa et al., 1992) . In the rat ureter, the contractile responses to tachykinins are mediated by NK 2 and NK 3 receptors (Maggi et al., 1998a) , whereas the receptor(s) responsible for the contractile eect of tachykinins in the guinea-pig ureter has not been characterized yet. In the guinea-pig isolated renal pelvis tachykinins produce positive inotropic and chronotropic eects on spontaneous rhythmic contractions (Maggi et al., 1992a,b) . Tachykinin receptors of the NK 2 and, at a lesser extent, of the NK 1 type mediate the eects of tachykinins in the guinea-pig isolated renal pelvis (Maggi et al., 1992a) .
Nerve ®bres containing tachykinin-like immunoreactive material (SP-and NKA-like immunoreactivity) are present in the human renal pelvis and ureter, showing a similar distribution to that observed in other species (Hua et al., 1987; Edyvane et al., 1992 Edyvane et al., , 1994 Zheng and Lawson, 1997) . Fewer information is available about the motor eect produced by tachykinins in the human ureter: to our knowledge the only report on this matter has been presented by Hua and coworkers (1987) , who described an excitatory motor response produced by NKA. However, no attempt was made to characterize the receptor(s) involved in the above responses to NKA.
In the present study we have investigated the motor and electrical activities exerted by natural and synthetic receptorselective tachykinin agonists in the human isolated ureter, with organ bath and sucrose-gap electrophysiological techniques. Similar experiments have been performed on the guinea-pig isolated ureter, aiming to characterize the tachykinin receptors mediating ureteral contraction in this species. To assess the involvement of NK 2 receptors, we used the receptor-selective antagonist MEN 11420 (Nepadutant) (Catalioto et al., 1998) , which was tested against exogenously-applied tachykinins in both the human and guinea-pig ureter. In addition, MEN 11420 was tested in the guinea-pig renal pelvis to block the excitatory motor eects produced by endogenous tachykinins released upon application of electrical ®eld stimulation (EFS).
Methods

General
All the experiments performed on human preparations were conducted on longitudinal muscle strips excised from the middle region of the ureter. Ureteral specimens were obtained from ®ve patients (three males and two females: age 60 ± 83 years) undergoing cystectomy or nephrectomy because of tumours. No patient had received radio-or chemotherapy before surgery. In all patients pre-anaesthetic medication was intramuscular atropine (1 mg) and diazepam (10 mg). Anaesthesia was induced by sodium thiopenthal (500 mg i.v.) and maintained with N 2 O/O 2 (1/2) and halothane (0.6 ± 1%). The patients received pancuronium bromide (6 mg i.v.) during induction of anaesthesia.
All specimens appeared macroscopically normal without signs of tumour or in¯ammation. Small longitudinal strips of ureter were prepared immediately after surgical removal and placed in ice-cold, gassed (96% O 2 and 4% CO 2 ) Krebs-Henseleit solution having the following composition in mM: NaCl, 119; NaHCO 3 , 25; KH 2 PO 4 , 1.2; MgSO 4 , 1.5; CaCl 2 , 2.5; KCl, 4.7 and glucose 11. The strips were kept at 48C overnight in oxygenated Krebs-Henseleit solution. The next day, 15 ± 20 h from excision, the strips were used for functional (organ bath) or sucrose-gap experiments.
Male albino guinea-pigs (250 ± 300 g) were stunned and bled. The whole kidney with ureter attached was rapidly removed and placed in oxygenated Krebs-Henseleit solution. The renal pelvis was carefully dissected from the renal parenchyma, separated from the ureter and cut in two halves, as described previously (Maggi et al., 1992a,b) . Both ends of the guinea-pig ureter were cut, and the middle portion was used for both functional and sucrose-gap experiments.
Organ bath experiments
Human ureteral strips (10 ± 15 mm long, 2 ± 3 mm wide), guinea-pig ureters and circular strips of the renal pelvis were set up on 5 ml organ baths, containing warmed (378C) and oxygenated (96% O 2 and 4% CO 2 ) Krebs-Henseleit solution and connected to isotonic force transducers against a load of ten (human ureter) or two (guinea-pig ureter or renal pelvis) mN. Indomethacin (3 mM) was added to Krebs-Henseleit solution for the experiments with the renal pelvis. All the experiments commenced after an equilibration period of 60 ± 90 min. In both the human and guinea-pig ureteral preparations NKA elicited the start of rhythmic contractions (or increased the frequency of a pre-existing motor activity) and produced also a tonic contractile response. Owing to the nature of this response, cumulative concentration-response curves to NKA could not be constructed, and a consecutive procedure of agonist application was adopted, as follows: 10 fold-increasing concentrations of NKA were administered to human or guinea-pig ureteral preparations every 30 min, left in contact with the tissue until a maximal response had developed (at least 5 min) and then washed out. MEN 11420 was tested against the motor response produced by a single submaximal concentration of NKA in both the human and guinea-pig ureter. In these latter experiments NKA (0.1 mM, given every 30 min) was administered until a reproducible response was obtained. MEN 11420 (0.1 mM) was added to the bath 15 min before the next challenge with NKA.
A separate series of experiments was performed in the guinea-pig renal pelvis, to assess the potency of MEN 11420 in blocking the eect of endogenous tachykinins at this level. Cumulative concentration-response curves to the tachykinin NK 2 receptor selective agonist [bAla 8 ]NKA(4 ± 10) were constructed: since a minor population of tachykinin NK 1 receptors exists in this preparation (Maggi et al., 1992a) , all the experiments were performed in the presence of the tachykinin NK 1 receptor antagonist SR 140333 (0.1 mM, 30 min before) (Emonds-Alt et al., 1993) to prevent stimulation of tachykinin NK 1 receptors by [bAla 8 ]NKA(4 ± 10) at high concentrations (see Patacchini et al., 1994) .
MEN 11420 was tested on matched strips of renal pelvis obtained from the same animal: one strip received the vehicle and served as control, and the other was pretreated with MEN 11420 (0.1 mM; 15 min incubation period), before constructing a cumulative concentration-response curve to the agonist. In the guinea-pig renal pelvis MEN 11420 was also tested against the nonadrenergic noncholinergic (NANC) contraction elicited by EFS (trains of 100 V, 0.25 ms duration, 5 Hz, for 10 s given every 30 min) in matched preparations. The contractile response to KCl (80 mM) was used as the internal standard in all experiments.
Sucrose-gap
In sucrose-gap experiments, human ureteral strips (10 ± 15 mm long, 0.5 ± 0.8 mm wide) and guinea-pig ureteral segments (10 ± 15 mm long) were prepared and placed in a 0.5 ml recording chamber. All preparations were continuously superfused (1 ml min 71 ) with oxygenated (96% O 2 and 4% CO 2 ) and warmed (35+0.58C) Krebs-Henseleit solution (composition as above) or, in the case of the guinea-pig ureter, with a modi®ed Krebs' solution deprived of Mg 2+ ions ( composition in mM: NaCl, 120.5; NaHCO 3 , 25; KH 2 PO 4 , 1.2; CaCl 2 , 2.5; KCl, 4.7 and glucose 11). The latter solution was used because in preliminary experiments we found that removal of Mg 2+ ions improves the reproducibility of action potentials evoked by EFS in the guinea-pig ureter. A single sucrose-gap, modi®ed as described by Artemenko et al. (1982) and Hoyle (1987) , was used to investigate simultaneously changes in membrane potential and contractile activity of the ureteral smooth muscles in response to chemical or electrical stimulation. All human and guinea-pig preparations were superfused with capsaicin (10 mM for 15 min), in order to block the eerent function of primary aerent neurons in the preparations. After a 60 min equilibration period, the preparations were stimulated by application of single electrical pulses (30 ± 40 V, 1 ± 5 ms pulse width) which were automatically delivered every 60 s. All drugs tested were administered by superfusion.
Concentrations of 1 and 3 mM of NKA, applied for 15 s, were selected for experiments in the guinea-pig and human ureter, respectively: these concentrations were selected from the knowledge on the potency of NKA in the producing a contraction of the guinea-pig and human ureter in organ bath experiments. In particular, the concentration of NKA tested was about 10 fold larger than the estimated EC 50 values (see results) in the two species. NKA was applied in superfusion every 45 min until reproducible responses were obtained.
All data were recorded and analysed by using a MacLab digital recorder system (AD Instruments).
Statistical analysis
The values in the text, tables or ®gures are expressed as means+95% con®dence limits (95% c.l.), or+s.e.mean. Statistical analysis was performed by means of Student's ttest for paired or unpaired data or by means of two-way analysis of variance (ANOVA), when applicable. Regression analysis of log concentration-eect curves was performed by the last squares method, considering the curves linear between 20 and 80% of the maximal response.
Evaluation of data
Agonist activity was expressed in terms of pD 2 . Antagonist anity of MEN 11420 tested at a single concentration was expressed as apparent pK B , which was estimated as the mean of the individual values obtained with the Gaddum-Schild equation: pK B log dose ratio À 1 À log antagonist concentration (see Kenakin, 1993; Jenkinson, 1991) In sucrose-gap experiments the latency of action potentials (APs) evoked by EFS was measured as the time interval between stimulus artifact and onset of the change in membrane potential. The time to peak of APs was calculated from the onset to the maximal value in membrane potential. The duration of the APs and contraction was calculated from their onset to 90% recovery of repolarization or relaxation respectively. azoniabi-cyclo[2,2,2]octane chloride] was kindly provided by Drs X. Emonds-Alt and G. Le Fur, Sano® (Montpellier, France).
Drugs
MEN 11420 (Nepadutant) (or: c{[(b-D-GlcNAc)Asn-Asp- Trp-Phe-Dpr-Leu]c(2b-5b)})(S)1-{2-[3-(3,4-dichlorophenyl)-1-(3- isopropoxyphenylacetyl) piperidin-n-3yl]ethyl}-4-phenyl-1-
Results
Organ bath experiments
Human and guinea-pig ureter Most preparations of human ureter (about 70 ± 80%) developed an irregular phasic contractile activity within 60 ± 90 min from set-up. The amplitude of this spontaneous activity averaged 40+7% (n=12) of the maximal response to KCl 80 mM, at a frequency of 1.8+0.4 contractions min 71 (n=12) and declined or even disappeared following the elicitation of contractile responses to NKA or KCl. On the other hand, all guinea-pig preparations were quiescent. The tachykinin NK 1 and NK 3 receptor-selective agonists septide and senktide (1 mM; n=4 each), respectively, failed to produce a contraction in either the human and guinea-pig isolated ureter. In contrast, NKA (10 nM ± 10 mM) evoked a concentration-dependent contraction in both the human (pD 2 =6.7+0.13; E max =89+4% of the response to KCl 80 mM, n=4) and guinea-pig ureter (pD 2 =7.2+0.07; E max =67+13% of the response to KCl 80 mM, n=4) ( Figures  1a and 2a ). In both cases the response to threshold concentrations of NKA consisted of a series of phasic contractions whereas at higher concentrations a tonic contraction developed onto which a series of phasic contractions superimposed (Figure 1a ).
MEN 11420 (0.1 mM; 15 min before) almost abolished (96+2% inhibition, n=4) the contraction produced by a submaximal concentration of NKA (0.1 mM) in the human ureter and greatly reduced (81+7% inhibition, n=4) the corresponding response evoked by NKA in the guinea-pig ureter (Figure 2b ).
Guinea-pig renal pelvis Circularly-oriented muscle strips from the guinea-pig renal pelvis showed a regular and long-lasting spontaneous phasic contractile activity, which persisted throughout the experimental period. Application of EFS produced a positive inotropic eect superimposed on the spontaneous activity ( Figure 1b ). MEN 11420 (10 nM ± 1 mM, 15 min before) inhibited in a concentration-dependent manner the response to EFS (Figure 1b) . At the highest concentration tested MEN 11420 (1 mM) almost abolished the EFS-induced contraction (90+6% inhibition; n=4).
The tachykinin NK 2 receptor-selective agonist [bAla 8 ] NKA(4 ± 10) (1 nM ± 3 mM), in the presence of SR 140333 (0.1 mM; 30 min before), produced a concentration-dependent contraction of the smooth muscle of the renal pelvis consisting of both a positivie chrono-and inotropic eect, as detailed previously (Maggi et al., 1992a,b) . MEN 11420 (0.1 mM; Each value is mean+s.e.mean of four to six observations. NKA (1 or 3 mM for 15 s, in guinea-pig or human preparations, respectively) was administered 5 min before recording its eect on the EFS (single pulses of 30 ± 40 V, 1 ± 5 ms pulse width). The eect of MEN 11420 (3 mM) on the response to EFS was recorded after a superfusion period of 20 min. a Signi®cantly dierent from the control value: P50.05. b Signi®cantly dierent from the control value: P50.01. 15 min before) produced a rightward shift of the curve to the NK 2 receptor agonist without depressing E max (not shown). An apparent pK B of 8.2+0.2 (n=4) was calculated from the agonist dose ratios.
Sucrose-gap
Human ureter All strips from the human ureter were mechanically and electrically quiescent. Application of EFS produced action potentials (APs) characterized by a rapidly rising depolarization, a sustained plateau and slow repolarization ( Figure 3a ; Table 1 ). Electrically-evoked APs were accompanied by phasic contractions (Table 1; Figure 3a) : both responses were unaected by tetrodotoxin (1 mM, n=3) .
Superfusion with either senktide or [Sar 9 ]SP sulphone (3 mM for 15 s for each agonist, n=4) did not produce any eect, whereas NKA (3 mM for 15 s; n=11) ( Figure 4a ) produced a slow membrane depolarization (5.0+0.7 mV), induced the appearance of Aps (amplitude 9.5+1.4 mV; frequency 9.1+1.6 cycles min 71 ) and produced smooth muscle contraction characterized by a tonic response (3.4+0.7 mN) with superimposed phasic activity (6.0+1.4 mN). The phasic contractions developed in parallel with the NKA-induced Aps (Figure 4a ). All the responses induced by 15 s superfusion of 3 mM NKA waned within 5 min from its application: at this time, the application of EFS elicited APs whose duration was signi®cantly prolonged as compared to control (about 70% increase), whereas the amplitude of APs was slightly reduced (about 13% decrease) (Table 1; Figure 3a) . The duration and amplitude of the accompanying phasic contraction were signi®cantly increased (about 44 and 25% increase, respectively) as compared to controls (Table 1; Figure 3a ).
Nifedipine (1 mM for 30 min, n=6) did not aect the resting membrane potential nor the tone of human ureter but completely blocked the APs and the phasic contraction induced by EFS (Figure 4b ). Nifedipine also completely prevented both APs and the concomitant phasic contractile activity elicited by NKA, and reduced (74+8% inhibition, P50.05, n=6) the tonic component of NKA-induced smooth muscle contraction, while leaving unchanged (7+13% reduction, n.s.) The amplitude of the slow membrane depolarization (Figure 4b ).
MEN 11420 (3 mM for 20 min, n=4) did not aect the resting membrane potential nor the amplitude of EFS-evoked APs and contraction of the human ureter (Figure 3b ). In contrast, MEN 11420 abolished both the electrical and motor responses produced by NKA (n=4, Figure 5a,b) , and completely prevented the eects of NKA on the APs and contraction elicited by EFS (Table 1; Figure 3c ).
Guinea-pig ureter All the preparations were mechanically and electrically quiescent. Application of EFS produced APs characterized by a rapidly rising depolarization followed by a plateau with superimposed spikes and repolarization (Table 1; Figure 4c ). Electrically-evoked APs were accompanied by phasic contractions (Table 1; Figure 4c ).
Likewise the eect observed in the human ureter, superfusion with NKA (1 mM for 15 s) produced a slow membrane depolarization with superimposed APs and smooth muscle contraction characterized by a tonic component and a phasic contractile activity: the latter developed concomitantly with the NKA-induced APs (Table 3 and Figure 4c ). As also observed in the human ureter, the amplitude of the EFSevoked APs, as measured 5 min after the administration of NKA, was reduced (about 11% inhibition) as compared to controls whereas their duration was signi®cantly longer (about 100% increase), and the number of spikes superimposed onto the plateau phase of APs were increased by NKA by about 50% (Table 1) . Also the duration and amplitude of the accompanying phasic contraction were increased by NKA (about 85 and 41% increase, respectively) ( Table 1) .
Nifedipine (1 ± 10 mM, 30 min before) produced a concentration-dependent inhibition of both electrical and mechanical responses to EFS. It has to be noted that 1 mM nifedipine, which eectively suppressed the EFS-evoked APs in the human ureter, was only eective in three out of eight cases tested in the guinea-pig ureter ( Table 2 ). In this preparation 10 mM nifedipine was required to suppress EFS-evoked APs in Each value is mean+s.e.mean. Nifedipine was administered to preparations 30 min before recording its eect on the response to EFS (single pulses of 30 ± 40 V, 1 ± 5 ms pulse width, given every min). Responders: number of preparations responding to EFS in control experiments or after pretreatment with nifedipine. The mean values shown were calculated on the data obtained in the responder preparations only. all cases tested, despite the fact that 1 mM nifedipine was sucient to abolish the concomitant contraction in all preparations (Table 2; Figure 4d ). The discrepancy is ascribable to a relative resistance of the ®rst spike of the EFS-evoked AP to nifedipine which was however unable to sustain a contraction. Notably, in the three preparations in which an AP was evoked by EFS in the presence of 1 mM nifedipine, the latency of the ®rst spike of the AP was not signi®cantly dierent from control. In these latter preparations, no plateau phase was evident, nor the multiple spikes which superimpose on the plateau could be observed (Table 2) Nifedipine (1 ± 10 mM, 30 min before) concentration-dependently reduced both the electrical and mechanical responses to NKA: even in this case, the contractile response was more sensitive to inhibition by nifedipine than the electrical response (Table 3 ). In particular, the slow membrane depolarization induced by NKA was largely nifedipine-resistant (about 25% inhibition at 10 mM nifedipine). Moreover, the NKA-evoked APs were relatively resistant to nifedipine since a concentration of 10 mM was required to completely eliminate this component of response (Table 3 ). All components of the contractile response were abolished by 10 mM nifedipine (Table 3 and Figure 4d ).
As also observed in the human ureter, MEN 11420 (3 mM for 20 min) did not aect the resting membrane potential and tone of the guinea-pig ureter, nor did it aect the electrical and mechanical responses to EFS. In contrast, MEN 11420 abolished all the electrical and motor responses produced by NKA (Figure 5c, d) and completely prevented the eects of NKA on APs and contraction elicited by EFS (Table 1 ).
Discussion
Our data indicate that, in both the human and guinea-pig ureter, tachykinins produce their excitatory eects by activating receptors of the NK 2 type only. This conclusion is based on the observation that synthetic receptor-selective agonists for the tachykinin NK 1 (septide and [Sar 9 ]SP sulphone) and tachykinin NK 3 receptors (senktide) (Wormser et al., 1986; Dion et al., 1987) have no eect, up to mmolar concentrations in both preparations. Moreover, all the excitatory responses produced by NKA were blocked by the NK 2 receptor-selective antagonist MEN 11420 (Catalioto et al., 1998) . MEN 11420 is a newly developed antagonist possessing high anity and selectivity for NK 2 receptor of several species, including human and guinea-pig Patacchini et al., 1997; Catalioto et al., 1998) . Up to 1 mM, MEN 11420 has low anity for tachykinin NK 1 /NK 3 receptors (pK B 56; Santicioli et al., 1997; Catalioto et al., 1998) . The speci®city of MEN 11420 in both the human and guinea-pig ureter is documented by the ineectiveness of this antagonist to reduce the response to EFS in sucrose-gap experiments, while it completely prevented the eects of NKA in the same preparations. Each value is mean+s.e.mean. Nifedipine was administered to preparations 30 min before recording its eect on the response to NKA (1 mM for 15 s). APs (number)=number of action potentials elicited by NKA. a Signi®cantly dierent from the control value: P50.05. b Signi®cantly dierent from the control value: P50.01. In the guinea-pig isolated renal pelvis MEN 11420 showed an anity for the NK 2 receptor (apparent pK B =8.2) comparable to that measured against NK 2 receptor agonists in other guinea-pig preparations such as the circular muscle of proximal colon (pK B =8.1, Santicioli et al., 1997) , main bronchus (pK B =8.4, Tramontana et al., 1998) and the common bile duct (pK B =8.2, Patacchini et al., 1997) . Application of EFS to the guinea-pig renal pelvis produces a contraction mediated by endogenous tachykinins, released by capsaicin-sensitive primary aerent endings (Maggi et al., 1992b) . Both NK 1 and NK 2 receptors are present in the renal pelvis but, based on the blocking action of antagonists, it was concluded that NK 2 receptor predominantly mediate the response to endogenous tachykinins unless degradation of endogenous peptides is reduced by peptidase inhibitors (Maggi et al., 1992a) . In the present experiments the NK 1 receptor antagonist, SR 140333 (Emonds-Alt et al., 1993) was used to occlude NK 1 receptors: MEN 11420 almost totally abolished the NANC contraction to EFS of the renal pelvis, at a concentration (1 mM) at which it is selective for the NK 2 receptor. This result further reinforces the conclusion, drawn from results obtained with less potent and selective tachykinin antagonists (Maggi et al., 1992a) , that NK 2 receptors provide the major contribution of the response to endogenous tachykinins and further validate the use of MEN 11420 as a tool to study tachykinin receptors in the pyeloureteral tract.
An important ®nding of the present study is that the NK 2 receptor is the predominant if not the exclusive mediator of the excitatory eect of tachykinins in the smooth muscle of the human ureter. This is in keeping with the results of previous studies, performed on smooth muscles from the human urinary bladder (Maggi et al., 1988b; Dion et al., 1990) , gastrointestinal (ileum, colon and oesophagus) (Maggi et al., 1989; Giuliani et al., 1991; Huber et al., 1993) and respiratory tract (Naline et al., 1989; Astol® et al., 1994; Dion et al., 1990) , although excitatory responses mediated by tachykinin NK 1 receptors have also been described in selected cases as the circular muscle of the human ileium (Zagorodnyuk et al., 1997) and small bronchi (Naline et al., 1996) .
The present ®ndings demonstrate that NKA, by occupying tachykinin NK 2 receptors, produces a slowly developing depolarization of the membrane in both the human and guinea-pig ureter: in both species the depolarizing response to NKA is substantially resistant to blockade by nifedipine at concentrations which eectively block the APs produced by electrical stimuli which excite latent pacemakers in the smooth muscle. Several mechanisms have been proposed to account for NKA-induced depolarization of smooth muscles which include suppression of outward potassium current (Nakazawa et al., 1990; Nakajima et al., 1995) , activation of calcium-dependent chloride current (Nakajima et al., 1995; Hazama et al., 1996) and activation of cation unselective channels (Lee et al., 1995) . Each one of these mechanisms may, in theory, underlie the NKA-induced depolarization of ureter smooth muscle. It is important to note that the nifedipine-resistant slow depolarization is associated with a tonic type contraction in the human but not in the guinea-pig ureter. Release of Ca 2+ ions from intracellular stores does not seem to contribute signi®cantly to excitation-contraction coupling in the guinea-pig ureter , while a signi®cant contribution of a receptoroperated calcium store to excitation-contraction coupling has been reported in the rat ureter (Burdyga et al., 1995) : a similar mechanism may contribute to the nifedipine-resistant tonic contraction of the human ureter to NKA.
In both the human and guinea-pig ureter, the depolarization induced by NKA triggers the appearance of a series of APs which are similar to those evoked by electrical stimuli: both the EFS-and the NKA-evoked APs were suppressed by nifedipine. In the guinea-pig, higher concentrations of nifedipine (up to 10 mM) were required to totally block APs and associated phasic contractions evoked by electrical stimuli (or NKA) than in the human ureter. This may be due to the fact that experiments in the guinea-pig ureter were performed in a nominally Mg 2+ -free medium which we found useful to improve the achievement of long term recording of excitatory responses to electrical stimuli: removal of Mg 2+ ions may have decreased the sensitivity of calcium channels to blockade by nifedipine. It is also worth noting that the relative resistance of the AP of the guinea-pig ureter to blockade by nifedipine is restricted to the ®rst spike, as also observed in previous studies (for e.g. Brading et al., 1983; Burdyga & Magura, 1986) which was also observed in this study.
Nifedipine eliminated with similar eectiveness the APs and the associated phasic contractions induced by NKA in both species, supporting the interpretation that the phasic contractility evoked by NKA is produced by the excitation of latent pacemakers which, in turn, produce a propagated contraction. This mechanism may be important for producing antiperistaltic waves of contraction if NKA is released in the ureter wall in response to stimuli (chemical or mechanical) capable of exciting primary aerent nerves.
Upon disappearance of its direct depolarizing and contractile eects, NKA still aected the EFS-evoked AP and contraction: the eect of NKA, which was similar in the human and guinea-pig ureter, consisted in a slight depression of the amplitude of the initial spike of the AP, in a prolongation of AP duration and in a potentiation of the contractile response. Similar modulatory eects of noradrenaline and histamine on the AP of the guinea-pig ureter to electrical stimuli were reported previously by Shuba (1977) . Shuba (1981) considered that a facilitation of the inward current could be held responsible for the prolongation of action potential induced by noradrenaline in the guinea-pig ureter. More recently Muraki et al. (1994) reported that noradrenaline actually inhibits the inward calcium current (I Ca ) in guinea-pig ureter smooth muscle cells and concomitantly inhibits the associated calcium-dependent potassium current I K(Ca) . According to Muraki et al. (1994) the inhibition of I K(Ca) is stronger than the concomitant inhibition of I Ca and this accounts for the net eect produced by noradrenaline on electromechanical coupling of the ureter. A similar mechansim may well account for the observed action of NKA on the AP of the guinea-pig and human ureter: in particular, the small but sizeable and statistically signi®cant decrease in the amplitude of the ®rst spike of the AP would be entirely consistent with a small inhibitory eect of NKA on I Ca .
In conclusion, the present study shows that the tachykinin NK 2 receptor predominates in producing the excitatory eects of tachykinins in the smooth muscle of the human and guineapig ureter. We have shown that the administration of NKA leads to excitation of latent pacemaker cells, and that NKA itself also exerts a facilitatory eect on EFS-induced APs in this preparation. Considering that tachykinins are present in nerve ®bres distributing to the human ureter and renal pelvis, it may be speculated that tachykinins released during pathological in¯ammatory conditions aect ureteral peristalsis: in particular tachykinins released in response to irritative stimuli could stimulate latent pacemakers and generate antiperistaltic waves of contractions. In this context, tachykinin NK 2 receptor antagonists, such as MEN 11420, may represent useful tools for assessing the pathophysiological role of these peptides in pyeloureteral tract.
